Banka Bioloo (BANKA)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Let me look at Banka Bioloo. At ₹72, the market cap is ₹63 Cr. I see a book value of ₹28.23, so I'm paying 2.55 times book. But what do I get for that? Returns on capital are negative at -7.61%. In other words, the enterprise is destroying value. Sales grew 8.69% last year, but to what end? The latest quarterly net profit is essentially ₹0 Cr. The reported profit growth of 89.73% is meaningless when starting from a base near zero. Debt to equity is 1.06, so there is leverage, but it is not generating a positive return. The Piotroski score of 6/9 is moderate, but not enough to offset poor economics. Promoter holding at 52.20% is decent and aligns interests, but good operators can still run bad businesses. No dividend; I have to rely on price appreciation, which is risky. The 52-week range shows the stock went from ₹41 to ₹97.88, so it has been speculative. As Graham would say, price is what you pay, value is what you get. Here I'm paying a premium to book for a company that cannot earn its cost of capital. I need a margin of safety. This looks like a potential turnaround situation, but I don't see evidence of a sustainable moat or improving returns. I would wait for clear proof of profitability and positive ROCE before putting any money here.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer